Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hakan Gunen

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Clinical Respiratory Journal|March 20, 2010
Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary diseaseOzkan Yetkin, Hakan Gunen
Sleep & Breathing = Schlaf & Atmung|May 16, 2008
CPAP compliance in patients with obstructive sleep apnea syndromeOzkan Yetkin, Erdogan Kunter, Hakan Gunen
Journal of Thoracic Disease|June 11, 2019
Efficacy and safety profile of roflumilast in a real-world experienceAykut Cilli, Halid Bal, Hakan Gunen
Current Medical Research and Opinion|April 10, 2020
Reply: Re: Yildiz BP, Bayraktaroglu M, Gunen H. Bronchodilator efficacy of tiotropium/formoterol (18/12 μg once daily via a discair inhaler), tiotropium alone (18 μg by handihaler) or combined with formoterol (12 μg twice daily by aerolizer) in adults with moderate-to-severe stable COPD. Curr Med Res Opin. 2019;35(12):2187-2196Birsen Pinar Yildiz, Mesut Bayraktaroglu, Hakan Gunen
Current Medical Research and Opinion|August 10, 2019
Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPDBirsen Pinar Yildiz, Mesut Bayraktaroglu, Hakan Gunen
Current Opinion in Pulmonary Medicine|June 18, 2009
Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?Hakan Gunen, Arzu Mirici, Mehmet Meral, et al.
International Archives of Occupational and Environmental Health|June 19, 2002
Proteolytic enzyme sensitivity and decrease in respiratory function (a 10-year follow-up)Ozkan Kizkin, Gamze Turker Suleyman, S Hacievliyagil, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 17, 2003
Asthma, age, and early reversibility testingOzkan Kizkin, Gamze Turker, Suleyman S Hacievliyagil, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2017
The role of tuberculosis in COPDHalil Ibrahim Yakar, Hakan Gunen, Erkan Pehlivan, et al.
Journal of Cardiac Surgery|September 7, 2007
A case of a large intrapericardial lipoma occupying pericardial space: an unusual complication of a coronary artery bypass surgeryFeridun Kosar, Isa Sincer, Akin Kuzucu, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Clinical Respiratory Journal|March 20, 2010
Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary diseaseOzkan Yetkin, Hakan Gunen
Sleep & Breathing = Schlaf & Atmung|May 16, 2008
CPAP compliance in patients with obstructive sleep apnea syndromeOzkan Yetkin, Erdogan Kunter, Hakan Gunen
Journal of Thoracic Disease|June 11, 2019
Efficacy and safety profile of roflumilast in a real-world experienceAykut Cilli, Halid Bal, Hakan Gunen
Current Medical Research and Opinion|April 10, 2020
Reply: Re: Yildiz BP, Bayraktaroglu M, Gunen H. Bronchodilator efficacy of tiotropium/formoterol (18/12 μg once daily via a discair inhaler), tiotropium alone (18 μg by handihaler) or combined with formoterol (12 μg twice daily by aerolizer) in adults with moderate-to-severe stable COPD. Curr Med Res Opin. 2019;35(12):2187-2196Birsen Pinar Yildiz, Mesut Bayraktaroglu, Hakan Gunen
Current Medical Research and Opinion|August 10, 2019
Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPDBirsen Pinar Yildiz, Mesut Bayraktaroglu, Hakan Gunen
Current Opinion in Pulmonary Medicine|June 18, 2009
Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?Hakan Gunen, Arzu Mirici, Mehmet Meral, et al.
International Archives of Occupational and Environmental Health|June 19, 2002
Proteolytic enzyme sensitivity and decrease in respiratory function (a 10-year follow-up)Ozkan Kizkin, Gamze Turker Suleyman, S Hacievliyagil, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 17, 2003
Asthma, age, and early reversibility testingOzkan Kizkin, Gamze Turker, Suleyman S Hacievliyagil, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2017
The role of tuberculosis in COPDHalil Ibrahim Yakar, Hakan Gunen, Erkan Pehlivan, et al.
Journal of Cardiac Surgery|September 7, 2007
A case of a large intrapericardial lipoma occupying pericardial space: an unusual complication of a coronary artery bypass surgeryFeridun Kosar, Isa Sincer, Akin Kuzucu, et al.
Pageof 3